I have some ties to the Medical field and have been hearing about the great interest in RP's new drug CombiPatch.There should be a news release on it that you can read.The first hormone replacement therapy (HRT) to combine both estrogen and progestin in a single transdermal patch is now available for Menopausal women....Previously women had only two options, either oral estogen and progestin or an estrogen transdermal patch used with an oral progesting...This should be a big boost for the company.Any thoughts on the matter?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat